203 related articles for article (PubMed ID: 3781670)
1. Development and clinical application of perfluorochemical artificial blood.
Ohyanagi H; Saitoh Y
Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
[TBL] [Abstract][Full Text] [Related]
2. Perfluorochemical emulsion oxygen transport fluids: a clinical review.
Tremper KK; Anderson ST
Annu Rev Med; 1985; 36():309-13. PubMed ID: 3888055
[TBL] [Abstract][Full Text] [Related]
3. Development of a perfluorochemical emulsion as a blood gas carrier.
Mitsuno T; Ohyanagi H; Yokoyama K
Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
[TBL] [Abstract][Full Text] [Related]
5. Medical oxygen transport using perfluorochemicals.
Kaufman RJ
Biotechnology; 1991; 19():127-62. PubMed ID: 1786469
[No Abstract] [Full Text] [Related]
6. Clinical experience with Fluosol-DA (20%) in the United States.
Tremper KK; Levine EM; Waxman K
Int Anesthesiol Clin; 1985; 23(1):185-97. PubMed ID: 3884514
[No Abstract] [Full Text] [Related]
7. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.
Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T
Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644
[TBL] [Abstract][Full Text] [Related]
8. Present status of clinical studies of Fluosol-DA (20%) in Japan.
Mitsuno T; Ohyanagi H
Int Anesthesiol Clin; 1985; 23(1):169-84. PubMed ID: 3980104
[TBL] [Abstract][Full Text] [Related]
9. Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?
Vox Sang; 1982 Feb; 42(2):97-109. PubMed ID: 7064434
[No Abstract] [Full Text] [Related]
10. Effect of Fluosol-DA on the reticuloendothelial system function in surgical patients.
Fujita T; Suzuki C; Ogawa R
Prog Clin Biol Res; 1983; 122():265-72. PubMed ID: 6878369
[No Abstract] [Full Text] [Related]
11. Red blood cell substitutes and artificial blood.
Bowman RJ
Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
[TBL] [Abstract][Full Text] [Related]
12. The use of fluorocarbon emulsions in cancer radiotherapy.
Guichard M
Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
[TBL] [Abstract][Full Text] [Related]
13. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
Bolin RB
Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
[TBL] [Abstract][Full Text] [Related]
14. A perfluorochemical emulsion as an oxygen carrier.
Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
[TBL] [Abstract][Full Text] [Related]
15. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies on fluosol DA administration in acute pancreatitis.
Ohyanagi H; Ohashi O; Nakayama S; Yamamoto M; Okumura S; Saitoh Y
Biomater Artif Cells Artif Organs; 1988; 16(1-3):585-94. PubMed ID: 3179491
[TBL] [Abstract][Full Text] [Related]
17. Modification of cerebral ischemia with Fluosol.
Peerless SJ; Nakamura R; Rodriguez-Salazar A; Hunter IG
Stroke; 1985; 16(1):38-43. PubMed ID: 3966263
[TBL] [Abstract][Full Text] [Related]
18. Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Suyama T; Yokoyama K; Naito R
Prog Clin Biol Res; 1981; 55():609-28. PubMed ID: 7027272
[TBL] [Abstract][Full Text] [Related]
19. Stability of perfluorocarbon blood substitutes determined by sedimentation field-flow fractionation.
Yang FS; Caldwell KD; Giddings JC; Astle L
Anal Biochem; 1984 May; 138(2):488-94. PubMed ID: 6742424
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of various colloidal solutions during major abdominal surgery.
Nishimura N; Hiranuma N; Sugi T
Crit Care Med; 1983 Dec; 11(12):940-2. PubMed ID: 6196154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
